[1] Song L, Zhao L, Deng J, et al. Staging liver fibrosis in patients with chronic hepatitis B using two-dimensional shear wave elastography based on histopathological findings: a prospective multicenter study. Quant Imaging Med Surg, 2023, 13(4):2376-2387. [2] Yoo HW, Kim SG, Jang JY, et al. Two-dimensional shear wave elastography for assessing liver fibrosis in patients with chronic liver disease: a prospective cohort study. Korean J Intern Med, 2022, 37(2):285-293. [3] Prieto Ortiz JE, Sánchez Pardo S, Prieto Ortiz RG, et al. Comparison of shear wave elastography (supersonic) with liver biopsy in a cohort of patients from a medium-income country: an observational study. Rev Esp Enferm Dig, 2021, 113(5):318-323. [4] 代海峰,王甜,雷迅,等.应用瞬时弹性成像技术联合APRI和AAR指数评估慢性乙型肝炎患者肝纤维化临床价值研究.实用肝脏病杂志,2021,24(2):196-199. [5] Kalkan Ç, Yılmaz Y, Erdo an BD, et al. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta. J Viral Hepat, 2023, 30(5):406-416. [6] Liu K, Qin M, Tao K, et al. Identification and external validation of the optimal FIB-4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings. J Clin Lab Anal, 2021, 35(2):e23640. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2022年版).实用肝脏 病杂志,2023,26(3)S18-39. [8] 中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识.中华肝脏病杂志,2002,10(5):327-328. [9] Bui HH, Nguyen ST, Phan ST, et al. Evaluating M2BPGias a marker for liver fibrosis in patients with chronic hepatitis B. Dig Dis Sci, 2023, 68(12):4407-4417. [10] Tosun M, Uslu H. Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B. Ultrasonography, 2022, 41(2):394-402. [11] Fu F, Li X, Chen C, et al. Non-invasive assessment of hepatic fibrosis: comparison of MR elastography to transient elastography and intravoxel incoherent motion diffusion-weighted MRI. Abdom Radiol (NY), 2020, 45(1):73-82. [12] Imajo K, Honda Y, Kobayashi T, et al. Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol, 2022, 20(4):908-917. [13] Karagiannakis DS, Markakis G, Lakiotaki D, et al. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol, 2022, 34(9):961-966. [14] Zhou X, Rao J, Wu X, et al. Comparison of 2-D shear wave elastography and point shear wave elastography for assessing liver fibrosis. Ultrasound Med Biol, 2021, 47(3):408-427. [15] Miodownik FG, Cardoso AC, Cancella Nabuco L, et al. Factors associated with disagreement of fibrosis stages between 2D-Shear wave elastography and transient elastography in chronic hepatitis B. Viruses, 2023, 15(4):846-857. [16] Osman AM, El Shimy A, Abd El Aziz MM. 2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis. Insights Imaging, 2020, 11(1):38-46. [17] Andrade TG, Xavier LCD, Souza FF, et al. Risk predictors of advanced hepatic fibrosis in patients with nonalcoholic fatty liver disease-a survey in a university hospital in Brazil. Arch EndocrinolMetab, 2022, 66(6):823-830. [18] Aksakal M, Oktar SO, Sendur HN, et al. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study. Abdom Radiol (NY), 2021, 46(7):3238-3244. [19] 汪涛,许愿,高静静,等.五种无创诊断指标对慢性乙型肝炎重度肝纤维化的诊断价值.中华消化杂志,2021,41(2):125-127. [20] 杨艳秋,程颢,冯敏.肝脏剪切波弹性成像对慢性乙型肝炎患者肝纤维化的评估价值.实用肝脏病杂志,2021,24(4):480-483. [21] Sapmaz FP, Büyükturan G, Sakin YS, et al. How effective are APRI, FIB-4, FIB-5 scores in predicting liver fibrosis in chronic hepatitis B patients? Medicine (Baltimore), 2022, 101(36):e30488. [22] Moosavy SH, Eftekhar E, Davoodian P, et al. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterol, 2023, 23(1):145-151. |